Medtronic Appoints Kate Cronin as Chief Marketing Officer for Diabetes Business Amid MiniMed Spin-off and Product Innovation Surge
Medtronic
Medical Device Manufacturer
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Source：Medical Device Business Review
On the morning of May 6, Medtronic announced the latest personnel appointment, and Kate Cronin will serve as the Chief Marketing Officer of its diabetes business.
This is another key personnel move by the department following the appointment of Dexcom's former executive Laura Endres as the head of the diabetes business in the Americas in April.
Cronin has many years of marketing experience.Cronin has been working at Moderna since 2021, responsible for promoting its COVID-19 vaccine. Last month, Kate Cronin had just left Moderna.
During his four-year tenure at Moderna, Cronin was responsible for building the company's brand and adjusting its image as the COVID-19 pandemic transitioned to an endemic phase.
Prior to this, she had worked at Ogilvy Health for 17 years, leaving the company as its Global CEO.
Earlier today, the executive wrote on her LinkedIn page: "I am thrilled to join the Medtronic Diabetes leadership team as Chief Marketing Officer – Medtronic Diabetes is the world’s leading diabetes company, committed to helping people forget about diabetes and live their best lives!"
"I am truly honored to embark on this adventure with a company so committed to fulfilling its mission and a dynamic, empathetic team," she added.
Image source: LinkedIn
Along with the restructuring of the executive team, Medtronic's diabetes business is entering a period of explosive product innovation:
At the end of last month, this medical technology giant announced that it had received FDA approval to pair its Simplera Sync blood glucose sensor with the MiniMed 780G insulin pump.
At the end of last year, Medtronic received FDA approval to launch a companion app designed to work with the InPen digital insulin pen and Simplera sensor.
At the same time, Medtronic is also seeking approval for an integrated diabetes management system that combines Medtronic's insulin pump and drug delivery algorithm with Abbott's continuous glucose monitoring technology, and submitted an application to the FDA at the end of last month.
#China MRI Report
#CT Report in China
# China Health Statistics Yearbook
# Survey on the Information Status of Hospitals in China
#Medical Ultrasound #Endoscopy #Monitoring #Cardiac Electrophysiology #Rehabilitation #Reproductive Health #Dentistry #Medical Aesthetics #Home Medical Device Field Report......
Reply to the keyword "8888”, can be claimed